Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:KURA), SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July 1, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards […]

Digi Power X Announces Proposed Shares for Debt Settlement with NANO Nuclear Energy

Digi Power X Announces Proposed Shares for Debt Settlement with NANO Nuclear Energy GlobeNewswire July 03, 2025 This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. NOT FOR DISTRIBUTION TO U.S. NEWS WIRE

Midland Begins Exploration Work on the Willbob-Kan Gold Project in the Labrador Trough

Midland Begins Exploration Work on the Willbob-Kan Gold Project in the Labrador Trough GlobeNewswire July 03, 2025 MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the beginning of his prospecting campaign in the Digeridoo area on its Willbob-Kan gold project, wholly owned by Midland. The Willbob-Kan

Bombardier to Report Second Quarter 2025 Financial Results on July 31st, 2025

Bombardier to Report Second Quarter 2025 Financial Results on July 31st, 2025 GlobeNewswire July 03, 2025 MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the second quarter of 2025 on July 31st, 2025. Financial results for the second quarter of 2025 Eric Martel, President and Chief Executive

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July 1, 2025, the Compensation

Levi & Korsinsky Notifies PepGen Inc. (PEPG) Investors – Lead Plaintiff Deadline on August 8, 2025

NEW YORK, NY / ACCESS Newswire / July 3, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=155389&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Class Action Lawsuit Filed: Bitfarms Ltd. (BITF) – Join by July 8, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 3, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=155388&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

BingX Partners with Cornix to Elevate Automated Trading Experience

BingX, a leading cryptocurrency exchange and Web3 AI company, is pleased to announce a strategic partnership with Cornix, an automated crypto trading platform that helps users follow expert traders, automate strategies, and manage their portfolios with ease. This collaboration enables users to connect their BingX accounts directly to Cornix, unlocking advanced automated trading tools and

Class Action Filed Against Sarepta Therapeutics, Inc. (SRPT) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / July 3, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=155379&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top